Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1362, 2002-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
ESRD costs and burden reduced with losartan in the EU
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. :
Access to resources
Recommend
ESRD with hyperphosphataemia: an economic burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 505, 2006-01 ,pp. :
Calculating cancer costs in the EU
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. :
Reduced catheter-related infections = reduced costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 625, 2011-01 ,pp. :
The Burden of Migraine in Spain: Beyond Direct Costs
By Badia X.
PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. :